Avalyn Pharma Inc. Common Stock (AVLN) — Defensive Interval Ratio
Avalyn Pharma Inc. Common Stock (AVLN) has a Defensive Interval Ratio of 2229 days as of December 2025. Defensive assets of $86.04 Million (cash $-, short-term investments $86.04 Million, receivables $-) cover 2229 days of daily cash needs of $38.61K/day. See Avalyn Pharma Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Avalyn Pharma Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Avalyn Pharma Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 2229 days, meaning defensive assets of $86.04 Million can fund 2229 days of operations without new revenue. Also explore Avalyn Pharma Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Avalyn Pharma Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Avalyn Pharma Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Avalyn Pharma Inc. Common Stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2229 days | $86.04 Million | $38.61K/day | $- | $86.04 Million | ▼ -1389 days |
| 2024 | 3618 days | $86.67 Million | $23.96K/day | $- | $86.67 Million | — |